- Home
- VATE vs GNTA Comparison
VATE vs GNTA Comparison
Compare VATE & GNTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | VATE | GNTA |
|---|---|---|
| Founded | 1994 | 2014 |
| Country | United States | Italy |
| Employees | N/A | 9 |
| Industry | Metal Fabrications | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 228.1M | 69.4M |
| IPO Year | 1996 | N/A |
Fundamental Metrics
Financial Performance| Metric | VATE | GNTA |
|---|---|---|
| Price | $7.83 | $1.57 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 92.1K | 72.2K |
| Earning Date | 05-14-2026 | 03-24-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $1,246,000,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 12.55 | N/A |
| 52 Week Low | $3.75 | $0.55 |
| 52 Week High | $21.30 | $10.00 |
Technical Indicators
Market Signals| Indicator | VATE | GNTA |
|---|---|---|
| Relative Strength Index (RSI) | 26.78 | 50.97 |
| Support Level | $4.38 | $1.30 |
| Resistance Level | $13.40 | $1.70 |
| Average True Range (ATR) | 0.87 | 0.13 |
| MACD | -0.13 | -0.00 |
| Stochastic Oscillator | 5.10 | 77.08 |
Price Performance
Historical ComparisonAbout VATE INNOVATE Corp.
Innovate Corp is a diversified holding company that has a portfolio of subsidiaries in a variety of operating segments. Its segments include Infrastructure, Life Sciences and Spectrum, and Other segment. Through its subsidiaries it provides fully integrated structural and steel construction services; supports healthcare and biotechnology product development; and operates Over-The-Air (OTA) broadcasting stations across the United States (U.S.) including Puerto Rico.
About GNTA Genenta Science S.p.A.
Genenta Science SPA is a clinical-stage biotechnology company engaged in the development of hematopoietic stem cell gene therapies for the treatment of solid tumors and cancer. The company's products include Temferon, a product to treat glioblastoma multiforme, a solid tumor affecting the brain.